DOI: 10.1055/s-00000004

Aktuelle Neurologie

References

Gan HK, Fichtel L, Lassman AB. et al.
A phase 1 study evaluating ABT-414 in combination with temozolomide (TMZ) for subjects with recurrent or unresectable glioblastoma (GBM).

J Clin Oncol 2014;
32 (Suppl. 05) abstr 2021

Download Bibliographical Data

Search in: